Scarica l'app Stockscreener
55.39
1.35%
0.74
Dopo l'orario di chiusura:
55.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TGTX Giù?
Forum
Previsione
Frazionamento azionario
Tg Therapeutics Inc Borsa (TGTX) Ultime notizie
TG Therapeutics (NASDAQ: TGTX) director plans $274,794.08 stock sale - Stock Titan
TG Therapeutics, Inc. (TGTX) Latest Stock News & Headlines - Yahoo Finance
TG Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference - Quiver Quantitative
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com India
TGTX: BRIUMVI targets $1B+ run rate, expanding with subQ and simplified dosing, backed by strong IP - TradingView
TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Stocktwits
TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth - Eastern Progress
TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 24.52% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TGTX Stock On Track For Best Day In 3.5 Months Amid Fresh Buyout Rumors - Stocktwits
TG Therapeutics to Participate in the Cantor Global Healthcare Conference - The Manila Times
(TGTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point - Investor's Business Daily
TG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86 - Moomoo
TGTX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $78 - GuruFocus
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $78 - Moomoo
TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Revenue Growth and Promising Potential Upside for Investors - DirectorsTalk Interviews
Price to book forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
TG Therapeutics (TGTX) Is Up 6.5% After Lifting 2026 Revenue Guidance on BRIUMVI Momentum - Sahm
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 28% Potential Upside with Innovative Biotech Solutions - DirectorsTalk Interviews
TGTX Rallies As TG Therapeutics Hikes 2026 Revenue Outlook - timothysykes.com
TG Therapeutics (TGTX) Stock Still Looks Cheap Even After Strong Returns - Sahm
TG Therapeutics Stock Jumps As Guidance Hike Fuels Takeover Buzz - timothysykes.com
TGTX Stock Alert: What to Know as Takeover Rumors Swirl Around TG Therapeutics - Yahoo Finance
TG Therapeutics Stock Jumps as Investors Reassess Growth Outlook - Quiver Quantitative
TGTX Stock Whipsaws As BRIUMVI Growth Fuels Bold 2026 Outlook - StocksToTrade
TGTX Stock Whipsaws As Guidance Jumps And EPS Miss Hits - timothysykes.com
TG Therapeutics (TGTX) Shares Surge 7.2% Amid Acquisition Rumors, Valuation Remains a Key Focus - GuruFocus
TG Therapeutics (TGTX) Stock Climbs 4% Amid Positive Market Sent - GuruFocus
Speculation on TG Therapeutics (TGTX) Acquisition Sparks Valuati - GuruFocus
Why is TG Therapeutics stock rallying today? By Investing.com - Investing.com Canada
Price to book forward of TG Therapeutics, Inc. – BX:NKB2 - TradingView
Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth with a Breakout Setup - ChartMill
TGTX Stock Jumps 5% On Positive Early Data For At-Home BRIUMVI In Muscle Disease - Stocktwits
TGTX Stock Rises 29% in 3 Months: Here's What You Should Know - qz.com
TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits
TGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss - Stocktwits
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection - TradingView
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a Potential 43% Upside in the Biotech Sector - DirectorsTalk Interviews
How TG Therapeutics’ Q2 2026 Revenue Surge And Higher Guidance At TG Therapeutics (TGTX) Has Changed Its Investment Story - Sahm
US High Growth Tech Stocks To Watch: 3 Top Picks - Sahm
TGTX Stock Slips After Earnings – But CEO's $1B Briumvi Outlook Keeps Retail Bullish - Stocktwits
Trading Systems Reacting to (TGTX) Volatility - Stock Traders Daily
Bank of America Corp DE Purchases 610,195 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
Assenagon Asset Management S.A. Lowers Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished - AOL.com
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):